Variant Pharmaceuticals, Inc. announced that it has received KRW 11.1001 billion in funding from Incon Co., Ltd.
December 02, 2018
Share
On December 3, 2018, Variant Pharmaceuticals, Inc. closed the transaction. The company the company has received $10,000,000 (KRW 11,100,100,000) from new investor, Incon Co., Ltd. (KOSDAQ:A083640). As the part of the transaction, Stephen C. Glover from Incon Co., Ltd. (KOSDAQ:A083640) will join company's board of director.
INCON Co., Ltd., formerly Win4Net Co., Ltd. is a Korea-based company specialized in the development and manufacture of digital video recorders (DVRs) used for security area. The Companyâs products consist of standalone DVRs, personal computer (PC)-based DVRs, analog cameras, color box cameras, indoor dome cameras, outdoor micro dome cameras, outdoor dome cameras and others. Its Internet protocol (IP) products include network video recorders (NVRs), video servers, hybrid DVRs, IP cameras and related software. It also provides storages. It distributes its products under the brand names of Netsafe, Trium, Poswatch, Clevo, Netsafe, Wintera and others. The Company distributes its products within domestic market and to overseas markets.
INCON CO.,LTD. 
